Croda International (GB:CRDA) has released an update.
Croda International reports a stable market performance with a sequential increase in sales driven by Consumer Care and Industrial Specialties, despite weaker Life Sciences sales due to decreased Crop Protection demand. The company highlights strong cashflow, a 69% increase in free cash flow, and the maintenance of its interim dividend, signifying financial resilience and commitment to shareholder returns. Additionally, strategic growth in key Pharma platforms and Consumer Care markets positions Croda for future earnings growth.
For further insights into GB:CRDA stock, check out TipRanks’ Stock Analysis page.
